Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating Gastric Acid Inhibition of Vonoprazan and Lansoprazole (PREVACID®)
27 sept. 2021 08h00 HE | Phathom Pharmaceuticals
Vonoprazan 20 mg demonstrated significantly greater acid suppressive effects over the 7-day study period compared to lansoprazole (PREVACID®) 30 mg, a proton pump inhibitor (PPI) FLORHAM PARK,...
Logo transparent PNG.png
PathMaker Neurosystems Announces Completion of Pivotal European Clinical Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
27 sept. 2021 05h00 HE | PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 27, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
vTv Graps Logo.png
vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
23 sept. 2021 16h30 HE | vTv Therapeutics Inc.
HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results build on data from previous multiple ascending dose study and support...
Global $11.5 Bn Virtual Clinical Trials Markets to 2028: Need for Patient Diversity Clubbed with Enhanced Data Collection is Boosting Growth
21 sept. 2021 06h58 HE | Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Virtual Clinical Trials Market Size, Share & Trends Analysis Report 2021-2028" report has been added to's offering....
Global $35 Billion Clinical Trials Support Services Markets to 2028 - Increasing Number Of CROs Providing Services
21 sept. 2021 06h13 HE | Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Support Services Market Size, Share & Trends Analysis Report by Phase, by Service (IRB, Clinical Trial Site Management,...
Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results of the First-in-Human Phase 0/1 Clinical Trial of Non-Invasive Sonodynamic Therapy for Recurrent Glioblastoma
20 sept. 2021 12h00 HE | Ivy Brain Tumor Center
PHOENIX, Ariz., Sept. 20, 2021 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, and...
Global Peptide Drug Conjugate Market & Clinical Trials Insights 2021-2026: Pepaxto Clinical & Commercial Insight - Dosage, Patent, Price, Sales Forecast
17 sept. 2021 04h03 HE | Research and Markets
Dublin, Sept. 17, 2021 (GLOBE NEWSWIRE) -- The "Global Peptide Drug Conjugate Market & Clinical Trials Insight 2026" report has been added to's offering. "Global...
Datavant _ BlueBlack (3) (1).png
Perspectum Announces Partnership with Datavant to Improve Clinical Trial Recruitment with Connected Data
16 sept. 2021 07h00 HE | Datavant
SAN FRANCISCO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Perspectum, a global quantitative and genomics-based imaging company, is joining forces with Datavant, the leader in helping healthcare...
Owkin Enters Into Agreement to Build Innovative Methods With the Potential to Enhance AI-Enabled External Control Arms
15 sept. 2021 09h00 HE | Owkin
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announces an agreement with Actelion...
Syneos Health_rgb_r.jpg
Syneos Health Acquires StudyKIK
14 sept. 2021 17h30 HE | Syneos Health, Inc.
MORRISVILLE, N.C., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of StudyKIK, a...